PUBLISHED ON: March 20, 2015 | Duration: 6 min, 49 sec
In an interaction with NDTV Profit, Kewal Handa, former MD of Pfizer, said that if USFDA adopts incentive-based policy in India, it will lead to faster-than-expected approval of drugs for companies.
